In a survey of more than 1000 Americans, nearly three-quarters gave the US health care system a grade of C or lower, highlighting widespread dissatisfaction with costs, access, and government regulation.1 Only half of respondents reported being able to afford […]
Americans Give US Health Care System a C Grade, Calling for Policy Change Read More »
Artificial intelligence (AI) has taken the country by storm in recent years, especially in the health care space. During the Association of Cancer Care Centers (ACCC) 51st Annual Meeting & Cancer Center Business Summit in Washington, DC, Douglas Flora, MD,
AI Is Not Going “Back in Pandora’s Box” in Cancer Care Read More »
At the Association of Cancer Care Centers (ACCC) 51st Annual Meeting & Cancer Center Business Summit in Washington, DC, Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC, reflects on his experience at ACCC Capitol Hill Day, where discussions with policy
On Capitol Hill, Experts Discuss Health Policy, PBMs, Drug Shortages, and More Read More »
The FDA approved the label expansion for furosemide injection (Furoscix; scPharmaceuticals) to treat edema caused by fluid buildup in patients with chronic kidney disease (CKD).1 Last year, the drug developer noted that FDA feedback from a 2023 Type D meeting
FDA Expands Furosemide Injection Label to Treat Edema in CKD Read More »
Ibrutinib remains a key treatment for relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL), but combining it with other therapies can significantly enhance patient outcomes, according to new research.1 A meta-analysis published in BMC Pharmacology and Toxicology included data from
Ibrutinib Benefits R/R CLL, but Combo Therapy Works Better Read More »
The House of Representatives passed a budget resolution (H Con Res 14, 119th Congress) that includes deep cuts to Medicaid, advancing the Republican-led plan in a 217-215 vote Tuesday evening.1 If the resolution becomes law, states could be forced to
House Passes Budget Resolution Cutting Billions From Medicaid Funding Read More »
During an Institute for Value-Based Medicine event in November 2024, experts in oncology highlighted how insurance coverage disparities and financial burdens limit equitable cancer care. In this interview, Susan Escudier, MD, FACP, medical oncologist and vice president of value-based care
The Need for Payer Support in Overcoming Cancer Care Disparities Read More »
Patients with extensive-stage small cell lung cancer (ES-SCLC) saw significant survival benefits when treated with either PD-1 or PD-L1 inhibitors combined with chemotherapy, according to a new meta-analysis.1 Researchers found no significant difference in OS and PFS for patients with
2 Immunotherapies Show Comparable Benefits in Extensive-Stage Small Cell Lung Cancer Read More »
At an Institute for Value-Based Medicine event in November 2024, experts discussed how social determinants of health worsen cancer care disparities in Houston, Texas. In this interview from the event, Susan Escudier, MD, FACP, medical oncologist and vice president of
Addressing Financial Toxicity and Clinical Trial Disparities in Community Oncology Read More »
Therapeutic inertia occurs when a patient’s treatment is not adjusted in a timely manner after not meeting their treatment goals. In diabetes and cardiometabolic care, addressing therapeutic inertia is essential to ensuring patients receive evidence-based treatments like sodium glucose co-transporter
Overcoming Barriers to Guideline-Directed Cardiometabolic Care Read More »
